tiprankstipranks
Inspire Medical sees Q4 revenue $137.5M-$137.9M, consensus $117.03M
The Fly

Inspire Medical sees Q4 revenue $137.5M-$137.9M, consensus $117.03M

Preliminary, Unaudited Revenue and Recent Business Highlights: Revenue for the fourth quarter of 2022 is anticipated to be in the range of $137.5 million to $137.9 million, an approximately 76% increase over the same quarter last year; Activated 61 new centers in the U.S. in the fourth quarter of 2022, bringing the total to 905 U.S. medical centers implanting Inspire therapy; Created 16 new sales territories in the U.S. in the fourth quarter of 2022, bringing the total to 225 U.S. sales territories. "We are very pleased with our strong preliminary revenue performance in the fourth quarter primarily driven by higher utilization at existing centers," said Tim Herbert, President and Chief Executive Officer of Inspire Medical Systems. "As we continue to activate new centers, we remain highly focused on consistent patient outcomes and enhanced center efficiencies which are the core of therapy adoption to meet robust demand. During the fourth quarter, we activated 61 new U.S. implanting centers, which was above our prior guidance of 52 to 56 new centers per quarter. To further support the growing demand for Inspire therapy, we created 16 new U.S. sales territories in the fourth quarter," continued Herbert. "Further, we grew revenue in Europe driven primarily by the performance in Germany, Switzerland and the Netherlands."

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on INSP:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles